Healthcare + Hospitals

MHRA finds UK public supports AI in healthcare if safety, effectiveness and ongoing oversight are guaranteed. What this means for regulators, clinicians and developers.

A concise look at how AI uses genomics, imaging and real-world data to deliver personalized treatments, plus short-term barriers and next steps for adoption.

AI solutions are integrated and the user is at the centre of every decision we take with development.

Zoya’s ZoyeMed 3.0 Resilience Edition runs advanced AI on-device with the Amygdala engine to deliver point-of-care diagnostics and continuity of care without internet.

Pacific AI’s CHAI-certified healthcare governance platform is now on AWS and Azure Marketplaces, offering in-tenant data residency, pay-per-credit pricing, and full AI lifecycle controls.

A concise update on how AI is reshaping diagnostics, personalized therapies, and proactive care, plus the real-world hurdles and strategic steps for clinical adoption.

Multimodal foundation models combine imaging, EHR, and genomics to improve diagnostics, speed drug discovery, and streamline clinical workflows while raising privacy and validation needs.

MHRA and NHS England launch the London Region I AI health regulatory sandbox to generate real-world evidence and fast-track safe AI medical devices.

MHRA’s AI sandbox aims to speed drug development, cut animal testing and build standards for predictive AI models. First phase due summer 2026.